SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Raymed Labs informs about newspaper advertisement

23 Aug 2024 Evaluate
Pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 Raymed Labs has informed that it attached Newspaper Advertisement with respect to the Notice of 32nd Annual General Meeting (AGM) to be held on Wednesday, 18th September, 2024, published in leading English Newspaper (Business Standard) and in Regional Language (Hindi) Newspaper (Business Standard Hindi Edition).

The above information is a part of company’s filings submitted to BSE.

Cresanto Global Share Price

4.65 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.45
Dr. Reddys Lab 1279.25
Cipla 1381.50
Zydus Lifesciences 1087.75
Lupin 2273.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: